Obesity-mediated atrial fibrillation, driven by NOX2-induced ROS production and modulation of PITX2, is mitigated by NOX2 inhibition, offering potential therapy insights. Here, CYBB is linked to obesity due to melanocortin 4 receptor deficiency.